Enter your keyword(s) (company name, disease target, therapeutic category, industry sector) into the search box and hit the search button to return reports matching your interests.
Searches on wide topic areas may take a moment to display, please be patient. If you have any queries about the report searching please contact us.
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there...
Romania - Health Care Report
Romania - Health Care Report offers a comprehensive review of the current state of the Romanian health care system, the pharmaceutical industry and the medical equipment market. It provides a business perspective on private and public service providers, updated statistics, and insights into the problems facing the system, as well as current economic developments and foreign investment information.
Optometrists and Opticians
The retail optical industry in the US includes about 14,000 optician stores with combined annual revenue of $7 billion, and 16,000 offices of optometrists with combined annual revenue of $6 billion. Large opticians include Luxottica Retail (LensCrafters and Pearle Vision), Eye Care Centers of America, and US Vision. The optician segment of the market is fairly concentrated: the 50 largest chains...
Thailand Pharmaceuticals and Healthcare Report Q1 2010
In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth totenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing andageing population represents a substantial commercial opportunity for drugmakers, although itscontroversial compulsory licensing scheme is deterring foreign investment, as is its political...
Australia Pharmaceuticals and Healthcare Report Q1 2010
Australia’s pharmaceutical market is among the most developed in the Asia-Pacific region. Access tomedication is good across all sections of the population, with per-capita spending calculated at US$352 in2008. While not particularly high by Western European or North American standards, it represents thesecond highest level in the region, behind only Japan. Over the next 10 years BMI...
| GlaxoSmithKline | Pfizer |
| Merck & Co | AstraZeneca |
| Johnson & Johnson | Aventis |
| Bristol-Myers Squibb | Novartis |
| Pharmacia | Wyeth |
| Roche | Takeda Chemical Industries |
| Bayer |
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
